Sergio V. Perrone

12.1k total citations · 1 hit paper
63 papers, 1.5k citations indexed

About

Sergio V. Perrone is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sergio V. Perrone has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Sergio V. Perrone's work include Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (12 papers). Sergio V. Perrone is often cited by papers focused on Heart Failure Treatment and Management (27 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (12 papers). Sergio V. Perrone collaborates with scholars based in Argentina, United States and Germany. Sergio V. Perrone's co-authors include Gerasimos Filippatos, Carolyn S.P. Lam, Saúl Soifer, Hernán C. Doval, Daniel Nul, Roberto Favaloro, Omar Scapín, Sergio Varini, Hugo Grancelli and Edgardo Kaplinsky and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Sergio V. Perrone

53 papers receiving 1.5k citations

Hit Papers

Effect of Empagliflozin on Cardiovascular and Renal Outco... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio V. Perrone Argentina 18 1.1k 318 285 285 174 63 1.5k
Sheryl L. Chow United States 16 758 0.7× 184 0.6× 179 0.6× 195 0.7× 122 0.7× 43 1.3k
Kenechukwu Mezue United States 13 659 0.6× 236 0.7× 157 0.6× 196 0.7× 151 0.9× 44 1.2k
Nobuyuki Shiba Japan 22 996 0.9× 153 0.5× 93 0.3× 289 1.0× 135 0.8× 55 1.5k
Maura Ravera Italy 25 1.1k 1.0× 278 0.9× 288 1.0× 172 0.6× 125 0.7× 61 1.7k
Kévin Duarte France 21 669 0.6× 211 0.7× 106 0.4× 294 1.0× 123 0.7× 80 1.1k
Justin Vader United States 21 1.1k 1.0× 297 0.9× 174 0.6× 462 1.6× 124 0.7× 76 1.6k
Charalampos Loutradis Greece 22 679 0.6× 278 0.9× 267 0.9× 437 1.5× 33 0.2× 89 1.4k
A.A. Voors Netherlands 14 1.1k 1.0× 332 1.0× 163 0.6× 157 0.6× 151 0.9× 22 1.5k
Radhakrishna R. Kallem United States 18 616 0.6× 182 0.6× 117 0.4× 173 0.6× 100 0.6× 25 1.2k
Iris Kingma Canada 21 685 0.6× 251 0.8× 106 0.4× 244 0.9× 114 0.7× 39 1.4k

Countries citing papers authored by Sergio V. Perrone

Since Specialization
Citations

This map shows the geographic impact of Sergio V. Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio V. Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio V. Perrone more than expected).

Fields of papers citing papers by Sergio V. Perrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio V. Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio V. Perrone. The network helps show where Sergio V. Perrone may publish in the future.

Co-authorship network of co-authors of Sergio V. Perrone

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio V. Perrone. A scholar is included among the top collaborators of Sergio V. Perrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio V. Perrone. Sergio V. Perrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tay, Wan Ting, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, et al.. (2025). Global Patterns of Polypharmacy After Acute Heart Failure Hospitalization: Prevalence and Outcomes from the REPORT-HF Registry. European Journal of Heart Failure. 27(12). 2705–2715.
2.
Tay, Wan Ting, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, et al.. (2025). Quality of care delivery in patients with acute heart failure: insights from the international REPORT-HF registry. EClinicalMedicine. 80. 103031–103031. 5 indexed citations
3.
Bistola, Vasiliki, Dimitrios Farmakis, Jasper Tromp, et al.. (2024). Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction. JACC Heart Failure. 13(2). 229–247. 2 indexed citations
4.
Farmakis, Dimitrios, Jasper Tromp, Smaragdi Marinaki, et al.. (2023). Impact of Left Ventricular Ejection Fraction Phenotypes on Healthcare Resource Utilization in Hospitalized Heart Failure: A Secondary Analysis of REPORT-HF. European Journal of Heart Failure. 25(6). 818–828. 3 indexed citations
5.
Barbagelata, Alejandro, et al.. (2023). Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO). Drugs in Context. 12. 1–15. 5 indexed citations
6.
Perrone, Sergio V., et al.. (2023). Dengue Myocarditis: A Case Report and Major Review. Global Heart. 18(1). 41–41. 9 indexed citations
7.
Ouwerkerk, Wouter, Jasper Tromp, John G.F. Cleland, et al.. (2022). Association of Time-to-Intravenous Furosemide with Mortality in Acute Heart Failure: Data from REPORT-HF. European Journal of Heart Failure. 25(1). 43–51. 9 indexed citations
8.
Tromp, Jasper, Wouter Ouwerkerk, John G.F. Cleland, et al.. (2021). Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure. JACC Heart Failure. 9(5). 349–359. 25 indexed citations
9.
Anker, Stefan D., Javed Butler, Gerasimos Filippatos, et al.. (2020). Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status. Circulation. 143(4). 337–349. 243 indexed citations breakdown →
10.
Vaduganathan, Muthiah, Brian Claggett, Akshay S. Desai, et al.. (2019). Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF. Journal of the American College of Cardiology. 75(3). 245–254. 100 indexed citations
11.
Filippatos, Gerasimos, Sadiya S. Khan, Andrew P. Ambrosy, et al.. (2015). International REgistry to Assess Medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): Rationale for and Design of a Global Registry. European Journal of Heart Failure. 17(5). 527–533. 46 indexed citations
12.
Ventura, Héctor O., et al.. (2011). Hipertensión pulmonar: la mirada del especialista. Redalyc (Universidad Autónoma del Estado de México). 6(2). 65–79. 3 indexed citations
13.
Carrascosa, Patrícia, Carlos Capuñay, Jorge Carrascosa, et al.. (2009). Certeza diagnóstica de la tomografía computarizada multicorte para la detección de la vasculopatía del injerto cardiaco: comparación con angiografía coronaria invasiva y ecografía intravascular. Revista Argentina de Radiología / Argentinian Journal of Radiology. 73(2). 161–167. 1 indexed citations
14.
Perrone, Sergio V.. (2009). Estrategia terapéutica en el tratamiento de la hipertensión arterial pulmonar. Redalyc (Universidad Autónoma del Estado de México). 4(1). 33–43. 4 indexed citations
15.
Hill, James A., Manfred Hummel, Randall C. Starling, et al.. (2007). A Lower Incidence of Cytomegalovirus Infection in De Novo Heart Transplant Recipients Randomized to Everolimus. Transplantation. 84(11). 1436–1442. 63 indexed citations
16.
Bocchi, Edimar Alcides, Marcos Amuchástegui, Fernando Boullón, et al.. (2006). Recommendations for Use of Everolimus After Heart Transplantation: Results From a Latin-American Consensus Meeting. Transplantation Proceedings. 38(3). 937–942. 10 indexed citations
17.
Castro, Pablo, et al.. (2006). Primer implante de sensor inalámbrico HeartSure® para monitoreo de presiones en arteria pulmonar de pacientes con insuficiencia cardíaca. Redalyc (Universidad Autónoma del Estado de México). 1(1). 56–57. 1 indexed citations
18.
Sigurðsson, Garðar, Patrícia Carrascosa, Neil L. Greenberg, et al.. (2006). Detection of Transplant Coronary Artery Disease Using Multidetector Computed Tomography With Adaptative Multisegment Reconstruction. Journal of the American College of Cardiology. 48(4). 772–778. 57 indexed citations
19.
Perrone, Sergio V., et al.. (2002). Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. Journal of the American Society of Echocardiography. 15(10). 1160–1164. 150 indexed citations
20.
Nul, Daniel, Hernán C. Doval, Hugo Grancelli, et al.. (1997). Heart Rate Is a Marker of Amiodarone Mortality Reduction in Severe Heart Failure. Journal of the American College of Cardiology. 29(6). 1199–1205. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026